Oryzon Genomics S.A. (BME:ORY)
2.945
-0.195 (-6.21%)
At close: Mar 2, 2026
Oryzon Genomics Market Cap
Oryzon Genomics has a market cap or net worth of €247.60 million as of March 2, 2026. Its market cap has increased by 92.27% in one year.
Market Cap
247.60M
Enterprise Value
234.61M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.95
Market Cap Chart
Since December 14, 2015, Oryzon Genomics's market cap has increased from 122.00M to 247.60M, an increase of 102.95%. That is a compound annual growth rate of 7.18%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.47B |
| Laboratorios Farmaceuticos Rovi | 4.33B |
| Almirall | 2.77B |
| Faes Farma | 1.62B |
| Pharma Mar | 1.38B |
| Clínica Baviera | 835.83M |
| Prim, S.A. | 232.27M |
| Atrys Health | 224.59M |